Open AccessOpioid Use for Pain Management After Implementation of a Medicaid Short-Acting Opioid Quantity Limit
Author(s) -
Catherine S. Riggs,
Sarah J. Billups,
Samantha Flores,
Rachana Patel,
Rachel M. F. Heilmann,
Jessica L. Milchak
Publication year - 2017
Publication title -
journal of managed care and specialty pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.126
H-Index - 63
eISSN - 2376-1032
pISSN - 2376-0540
DOI - 10.18553/jmcp.2017.23.3.346
Subject(s) - medicaid , medicine , opioid , hydromorphone , medical prescription , population , emergency medicine , pharmacy , family medicine , environmental health , health care , nursing , economic growth , receptor , economics
The United States is currently experiencing an opioid abuse epidemic. Many policies and programs have been implemented at local, state, and national levels in an attempt to decrease prescription opioid addiction and overdose. On August 1, 2014, Colorado Medicaid implemented a policy change that limited the quantity of short-acting opioids (SAOs) that could be filled through the Medicaid benefit to no more than 4 tablets per day, or 120 tablets in 30 days.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom